BR112018014069A2 - uso de uma dieta de reforço e imitação de jejum, uso de uma dieta de reforço e imitação de jejum com um agente quimioterápico, e pacote de dieta. - Google Patents

uso de uma dieta de reforço e imitação de jejum, uso de uma dieta de reforço e imitação de jejum com um agente quimioterápico, e pacote de dieta.

Info

Publication number
BR112018014069A2
BR112018014069A2 BR112018014069A BR112018014069A BR112018014069A2 BR 112018014069 A2 BR112018014069 A2 BR 112018014069A2 BR 112018014069 A BR112018014069 A BR 112018014069A BR 112018014069 A BR112018014069 A BR 112018014069A BR 112018014069 A2 BR112018014069 A2 BR 112018014069A2
Authority
BR
Brazil
Prior art keywords
fasting
diet
imitation
package
chemotherapeutic agent
Prior art date
Application number
BR112018014069A
Other languages
English (en)
Inventor
D Longo Valter
E Wright Woodring
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of BR112018014069A2 publication Critical patent/BR112018014069A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

trata-se de um método para tratar um indivíduo com mieloma múltiplo que inclui uma etapa de identificar um paciente que tem mieloma múltiplo. uma dieta de reforço e imitação de jejum é administrada ao indivíduo em um período de tempo predeterminado de pelo menos 8 dias. é fornecido também um pacote de dieta para implantar o método.
BR112018014069A 2016-01-12 2017-01-12 uso de uma dieta de reforço e imitação de jejum, uso de uma dieta de reforço e imitação de jejum com um agente quimioterápico, e pacote de dieta. BR112018014069A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662277649P 2016-01-12 2016-01-12
PCT/US2017/013158 WO2017123733A1 (en) 2016-01-12 2017-01-12 Use of long-term fasting mimicking as dietary treatment for multiple myeloma and other cancers

Publications (1)

Publication Number Publication Date
BR112018014069A2 true BR112018014069A2 (pt) 2018-12-11

Family

ID=59311494

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018014069A BR112018014069A2 (pt) 2016-01-12 2017-01-12 uso de uma dieta de reforço e imitação de jejum, uso de uma dieta de reforço e imitação de jejum com um agente quimioterápico, e pacote de dieta.

Country Status (12)

Country Link
US (1) US20190029301A1 (pt)
EP (1) EP3402345A4 (pt)
JP (2) JP2019504073A (pt)
KR (1) KR20180094108A (pt)
CN (1) CN108463121A (pt)
AU (1) AU2017207370B2 (pt)
BR (1) BR112018014069A2 (pt)
CA (2) CA3009664C (pt)
HK (1) HK1258621A1 (pt)
MX (1) MX2018008555A (pt)
WO (1) WO2017123733A1 (pt)
ZA (1) ZA201805338B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11284640B2 (en) 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
CN112153974A (zh) 2018-03-15 2020-12-29 南加利福尼亚大学 禁食模仿膳食(fmd)而非仅饮水禁食促进炎症和ibd病理学的逆转

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081678A1 (en) * 2002-08-09 2004-04-29 Anthony Cincotta Therapeutic process for the treatment of obesity and associated metabolic disorders
MX2007012450A (es) * 2005-04-06 2008-02-12 Novartis Ag Un metodo y composicion para mejorar nutricionalmente el control de la glucosa y la accion de la insulina.
US8821947B2 (en) * 2006-06-01 2014-09-02 Howard W. Selby, III Cholesterol-reducing diet
PT2490684T (pt) * 2009-10-22 2018-04-02 Univ Southern California Métodos e formulações nutricionais para aumentar a eficácia e reduzir os efeitos secundários do tratamento oncológico
CN102892421A (zh) * 2010-03-10 2013-01-23 伊诺沃生物公司 用于治疗代谢病症的包含葡甘露聚糖、黄原胶和藻酸盐的食物
GB201011771D0 (en) * 2010-07-13 2010-08-25 Bioinvent Int Ab Biological material and particular uses thereof
JP6325555B2 (ja) * 2012-10-22 2018-05-16 ユニバーシティ オブ サザン カリフォルニア 組織／器官再生、寿命、およびヘルススパンを増進する方法および製剤
CN114236130A (zh) * 2013-02-12 2022-03-25 南加利福尼亚大学 用于减轻年龄相关症状的膳食包装
KR102410769B1 (ko) * 2013-07-01 2022-06-20 유니버시티 오브 써던 캘리포니아 당뇨병의 식이 요법으로서의 공복 상태
MX2016011361A (es) * 2014-03-06 2017-05-08 Univ Southern California Utilización de régimen de ayuno a corto plazo en combinación con inhibidores de cinasa para potenciar la eficacia y viabilidad de fármacos quimioterápicos tradicionales e invertir los efectos secundarios de cinasas en células y tejidos normales.

Also Published As

Publication number Publication date
AU2017207370A1 (en) 2018-07-19
EP3402345A1 (en) 2018-11-21
CA3009664C (en) 2024-02-13
CA3009664A1 (en) 2017-07-20
WO2017123733A1 (en) 2017-07-20
CN108463121A (zh) 2018-08-28
EP3402345A4 (en) 2019-09-11
HK1258621A1 (zh) 2019-11-15
JP2021183622A (ja) 2021-12-02
JP2019504073A (ja) 2019-02-14
ZA201805338B (en) 2019-11-27
MX2018008555A (es) 2019-05-30
KR20180094108A (ko) 2018-08-22
US20190029301A1 (en) 2019-01-31
CA3224535A1 (en) 2017-07-20
AU2017207370B2 (en) 2021-09-23

Similar Documents

Publication Publication Date Title
BR112018008709A2 (pt) artigo para uso com aparelho para aquecer o material de fumo para volatilizar pelo menos um componente do material de fumo e aparelhos para aquecer o material de fumo para volatilizar pelo menos um componente do material de fumo
BR112018003984A2 (pt) anticorpos
BR112017005693A2 (pt) método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica.
BR112017028194A2 (pt) moduladores de diaciglicerol aciltransferase 2 (dgat2)
MX2020013557A (es) Un esteroide de c21-pirazolilo disustituido con 19-nor c3,3 y métodos de uso del mismo.
BR112018073298A2 (pt) cápsula, suspensão de cápsula, mistura, uso das cápsulas e método para reduzir a nitrificação
CL2018002727A1 (es) Medicina obtenida mediante la combinación de agonista fxr y arb
BR112017022089A2 (pt) uso de uma composição, e, método para branqueamento de dentes
BR112017014361A2 (pt) métodos para aperfeiçoamento de terapia celular
CL2021000650A1 (es) Moduladores de la expresión de pnpla3
CL2017002214A1 (es) Formulación de combinación de tesofensina y betabloqueante
BR112017027277A2 (pt) ?método para o tratamento ou prevenção de uma doença e métodos para matar uma célula?
BR112016028639A2 (pt) composição de tintura de cabelo
BR112019005040A2 (pt) aplicação de pridopidina para tratamento de síndrome de rett
CR20190471A (es) Moduladores de la expresión de pcsk9
BR112017027600A2 (pt) composição de fragrância, produto de consumo e método para reduzir ou inibir a resposta ao estresse em um indivíduo necessitando do mesmo
BR112018008911A2 (pt) composições compreendendo vetores lentivirais que expressam il-12 e métodos de uso das mesmas
BR112018014547A2 (pt) placa de gesso
BR112018014069A2 (pt) uso de uma dieta de reforço e imitação de jejum, uso de uma dieta de reforço e imitação de jejum com um agente quimioterápico, e pacote de dieta.
BR112018068817A2 (pt) beta-caseínas e função cognitiva
BR112017010428A2 (pt) composição para tratar dor aguda, pós-operatória ou crônica em um indivíduo, método para tratar um indivíduo tendo dor aguda, pós-operatória ou crônica e kit para produzir a composição
CO2020003134A2 (es) Moduladores de la expresión de enac
BR112016008901A2 (pt) Compostos para uso na prevenção e tratamento de doenças neurodegenerativas e da dor.
BR112019004413A2 (pt) método para criar um padrão em um material natural de origem humana ou animal, material natural de origem humana ou animal, e, uso de um material natural.
CL2020001851A1 (es) Moduladores de la expresión dnm2

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements